SEC Company Response from ABBOTT LABORATORIES (ABT) — May 10, 2017
ABBOTT LABORATORIES
Date: May 10, 2017 · CIK: 0000001800 · Accession: 0001104659-17-031561
AI Filing Summary & Sentiment
File numbers found in text: 001-02189
Letter
United States Securities and Exchange Commission Division of Corporation Finance 100 F Street NE Washington, D.C. 20549 Attention: Sasha Parikh Kevin Vaughn
RE: File Number 001-02189
Dear Ms. Parikh and Mr. Vaughn:
In reply to your letter of May 8, 2017, we have enclosed our response in the attachment to this letter.
Very truly yours,
/s/ Brian Yoor
Show Raw Text
CORRESP 1 filename1.htm May 10, 2017 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street NE Washington, D.C. 20549 Attention: Sasha Parikh Kevin Vaughn RE: File Number 001-02189 Dear Ms. Parikh and Mr. Vaughn: In reply to your letter of May 8, 2017, we have enclosed our response in the attachment to this letter. Very truly yours, /s/ Brian Yoor Brian B. Yoor Executive Vice President, Finance and Chief Financial Officer Enclosure Form 8-K filed January 25, 2017 Exhibit 99.1 NON-GAAP RECONCILIATION OF FINANCIAL INFORMATION FROM CONTINUING OPERATIONS, page 14 1. Regarding your response to our prior comment 1 of our March 29, 2017 letter, please confirm to us that you will revise your future filings to provide a similar level of detail regarding your non-GAAP adjustments. As part of such disclosure, clearly quantify each ‘specified item’ noted in the disclosure. For example, in the first table of ‘Non-GAAP Reconciliation of Financial Information From Continuing Operations for the Fourth Quarter Ended December 31, 2016 and 2015’ on page 14, you disclose that specified items reflect “...other expenses of $196 million, primarily associated with acquisitions, including bridge facility fees and other debt related costs, charges related to cost reduction initiatives and other expenses”. In this regard, separately discuss and quantify each ‘specified item’ noted rather than an aggregate amount. Response: We confirm that in future earnings releases we will provide a level of detail regarding our non-GAAP adjustments that is similar to the level of detail provided in our April 11, 2017 response, showing the amount and description of each specified item.